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Received 19 May 2009; received in revised form 21 December 2009; accepted 22 December 2009Abstract This study sought to identify the gene expression patterns of porcine bone marrow-derived MSC in response to
hypoxia and to investigate novel specific hypoxic targets that may have a role in determining MSC proliferation/survival and
differentiation. MSC from 15 animals were incubated in 1% oxygen and 8% carbon dioxide for 6, 12, and 24 h. RNA samples were
isolated and assayed with Affymetrix porcine arrays and quantitative reverse-transcription PCR. Significant gene expression
levels among the four groups of normoxia, 6-, 12-, and 24-h hypoxia were identified. The pattern in the 12-h hypoxia group was
similar to that of the 24-h group. Of 23,924 probes, 377 and 210 genes were regulated in the 6- and 24-h hypoxia groups,
respectively. Functional classification of the hypoxic regulated genes was mainly clustered in cell proliferation and response to
stress. However, the major upregulated genes in the 6-h group were activated in cell cycle phases; the genes in the 24-h hypoxia
were evenly separated into cell differentiation, apoptosis, and cellular metabolic processes. Twenty-eight genes were
upregulated in all hypoxia groups; these genes are considered as hypoxic targets. Our results identified a genome-wide
hypoxia-induced gene expression pattern in porcine MSC. This study provides a global view of molecular events in the cells
during exposure to hypoxia and revealed a set of novel candidate hypoxic targets.
Published by Elsevier B.V.Introduction
Mesenchymal stem cells (MSC) are self-renewing and multi-
potent cells capable of differentiating into multiple cell
types, osteocytes, adipocytes, myocytes, and endothelial
progenitor cells (Barry, 2003; Bobis et al., 2006). Adult
human MSC can be isolated from bone marrow, adipose
tissue, umbilical cord blood, lung, and liver (Festy et al.,⁎ Corresponding author. Fax: +1 301 480 5145.
E-mail address: wangs3@mail.nih.gov (S. Wang).
1873-5061/$ – see front matter. Published by Elsevier B.V.
doi:10.1016/j.scr.2009.12.0022005; Jeong et al., 2005; Kermani et al., 2008). Recent
studies have shown that after myocardial infarction, limited
tissue regeneration can be achieved through the differenti-
ation of resident cardiac stem cells or circulating progenitor
cells mobilized from bone marrow (Iop et al., 2008; Yau
et al., 2005). Several researchers have shown that bone
marrow-derived MSC (BM-MSC) enhance endothelial pro-
genitor cell regeneration under ischemic or hypoxic condi-
tions (Belanger et al., 2002; Brat et al., 2003). Additional
studies reported that autologous MSC are able to improve
cardiac function in swine and rat infarction models (Shake
et al., 2002; Tang, 2005). Despite these recent discoveries,
molecular mechanisms that govern MSC self-renewal,
118 S. Wang et al.expansion, migration, and multilineage differentiation under
ischemic or hypoxic conditions are not well understood.
Analysis of a genome-wide expression profiling has been
used in the assessment of cancer progression, prediction of
diagnostic biomarkers, and evaluation of outcomes of gene
therapy (Wang et al., 2006; Xu et al., 2002). The hypoxia-
induced gene expression profiles of human, mouse, and rat
BM-MSC have been demonstrated based on each different
experimental setting (Martin-Rendon et al., 2007; Ohnishi
et al., 2007). We hypothesize that the gene expression
profile in BM-MSC under hypoxic conditions provides a
dynamic picture of ongoing molecular activities in the cells
as they adapt to the microenvironment. Elucidating this
genomic response may guide us to a better understanding of
molecular mechanisms of the cells' response to hypoxia and
aid the detection of novel hypoxic targets for further study.
Swine have been used as an excellent preclinical large
animal research model for wound repair, reproductive
diseases, cancer, diabetes, and cardiovascular diseases
studies (Eckert et al., 2009; Ben-Yosef et al., 2009; Zhang
et al., 2007). In genomic basis terms, pigs are analogous to
humans.GeneChip PorcineGenomeArray is a valuable tool for
investigating gene expression patterns in the porcine animal
model. Nevertheless, its application has been limited by the
lack of genomic information in pig gene resources. (http://
www.ncbi.nlm.nih.gov/projects/genome/guide/pig/).
In this study, we focused on the molecular changes that
lead to injury or adaptation to hypoxic stress using porcine
bone marrow-derived stem cells as an in vitro mode system.
Our goals are to establish a comprehensive profiling of swine
hypoxic transcripts and to discover new hypoxic targets that
may determine stem cell survival and differentiation. To
achieve these aims, we conducted a porcine BM-MSC
microarray based on expression profilings at various time
points following exposure to hypoxia. This was in order to
catch a dynamic biological process of cellular adaptation to a
low oxygen microenvironment. We present a wide range of
assessments of gene expression patterns in adult porcine BM-
MSC in response to hypoxia, along with an investigation of
specific hypoxic targets that may be involved with the
processes of repairing ischemic cells or tissues. To better
understand swine hypoxia modulated targets, we completed
a number of the hypoxia-induced porcine transcripts'
genomic information utilizing human genomic information.
The data were also compared with the hypoxic genes
expression patterns in non-stem cells from the same species,
swine aorta-derived fibroblast cells (aFBC) by quantitative
RT-PCR (qRT-PCR) in order to further understand the
molecular activities within MSC or fibroblast when they
respond to low oxygen stress.Results
Identification of gene expression profile in MSC
Using the gene expression pattern as a guide, we first
searched samples from both normoxic and hypoxic conditions
for differential patterns and relationships among those
patterns using GeneSprinGX9.0 and Prediction Analysis of
Microarray (PAM) software. The results of both analyses
showed that all samples were gathered into twomajor groups:normoxia and hypoxia. The 10× cross-validation probabilities
for each given sample were found by PAM, which indicated
that all five samples in the N (normoxia) group were clearly
distinct from any of the other three hypoxic (H) groups
(Fig. 1A). As shown in Fig. 1, the distinct expression patterns
of the 6-h H and 24-h H were also identified. The samples in
the 12-h H, however, were somewhat less distinct and more
like those in either the 24-h H or the 6-h H, with the majority
being similar to the 24-h H group.Identification of differentially regulated genes in
the hypoxic group
To identify significant differentially regulated hypoxic
targets, multiple microarray analyses were performed. The
normoxic group, as baseline control, was compared with
each hypoxic group. The significant differentially expressed
genes among N, 6-, 12-, and 24-h H groups were identified
concurrently by analysis of variance (ANOVA) at P≤0.05
(GeneSpringGX9.0) and Significance Analysis of Microarray
(SAM) (FDRb0.1, fold change≥2). Of the 20,201 genes
analyzed, 377 genes were rapidly regulated in the 6-h H
group compared to the N group. Only 182 genes were
differentially expressed in the 12-h H group compared with
the N group. Eighty-one percent (148/181) of the genes
appeared as a similar regulation pattern in either the 6- or
the 24-h H groups, indicating that there is no specific
transcriptional expressional pattern in this 12-h H group. This
outcome further confirmed the finding in another analysis of
sample classification by PAM. According to this data set, the
observations suggest that there was no specific gene
expression profile in 12-h H. Therefore, we selected 6- and
24-h H time points for further analysis.
Two hundred and ten genes were significantly up- or
downregulated in 24-h H (Fig. 1B). As seen, 68% (255/377) of
the regulated genes were overexpressed in 6-h H, and
roughly equal numbers of up- and downregulated genes were
overexpressed in 24-h H. One hundred and six genes shared a
similar expression pattern in the 6- and 24-h Hs; among
those, 93 genes overlapped in the 6-, 12-, and 24-h Hs
(Figs. 1C and D). Notably, these 93 genes were the most
differentially modulated in all three hypoxic groups.
Fifty-three of the 106 in-common porcine-transcribed loci
are highly similar to matched human transcripts with their
protein similarity of over 80%. Among the 53 genes, VEGFA,
PDGFA, SOX9, BNIP3, HES1, JUN, IGF1, and PLAGL1 have
been known to be hypoxic targets and play important roles in
low oxygen or ischemia-induced angiogenesis signaling, cell
proliferation, survival, and apoptosis pathways (Belanger
et al., 2002; Brat et al., 2003; Beitner-Johnson et al., 1997;
Chang et al., 2007; Kenneth and Rocha, 2008; Koritzinsky
et al., 2006) (Table 1).
By analyzing the gene expression profile, we recon-
structed two main phases of cellular response to hypoxia:
rapid response (6-h H) and adaptive response (24-h H). We
also obtained a set of 106 genes that were modulated
consistently under hypoxic conditions. The discovery of
these gene sets is an incentive for advanced functional
annotation in gene ontology (GO). Additionally, novel
unknown genes may be discovered to play important roles
in the cellular response to hypoxia.
Figure 1 Overview of the gene expression pattern in the cells during exposure under hypoxic conditions. (A) The summary of PAM,
showing 10× cross-validation probabilities for each given sample. Each sample's classification is marked by the symbols explained in
the key at the bottom of the graph. All the samples of the 6-h hypoxic and normoxia are classified correctly; however, 4 and 2 of 12-
and 24-h hypoxia are misclassified, respectively. (B) The bar graph illustrates the features of the up- or downregulated genes in three
hypoxic groups. Compared to normoxia, the upregulated genes in the 6-h hypoxia are almost two times greater than the
downregulated genes. However, the numbers of upregulated genes in 24-h hypoxia are close to the number of downregulated genes.
(C) A paired analysis of significant gene expression in the 6-h H vs N and 24 h H vs N. The left Venn diagram represents the total
number of genes that were significantly differentially expressed between the 6-h hypoxia, whereas the right Venn diagram represent
the total number of genes significantly differentially expressed between 24-h hypoxia and normoxia. (D) A profile plot that
summarized an analysis from GenespringGX9.0 displayed a dynamic gene regulation profile in cells during exposure in hypoxia in
different time points. All hypoxia groups compared to the normoxia, each line represents one gene. The red color signifies that the
gene was highly expressed in normoxia and lower expressed in hypoxic samples and blue denotes a lower expressed gene in control but
higher in hypoxic groups.
119The transcriptional changes of pig MSC in hypoxiaFunctional classification and pathway search
To obtain the distinctive biological functional uniqueness of
the modulated genes in the 6- and 24-h H groups; 223 and 113
significant modulated transcripts in the 6- and 24-h H groups
were analyzed, respectively. The porcine-transcribed loci
(Ssc.) with high protein similarities to human (over 80%) were
annotated via DAVID and GeneGo for their biological
processes in signaling pathways. The analyzed functional
classifications are briefly summarized in Table 2 and Fig. 2.
As shown, the most enhanced cellular pathway in the 6-h H
group was cell cycle (KEGG term 04110). Twenty genes,
GADD45β (growth arrest and DNA-damage-inducible β),
PCNA, CDK1–2, Cyclin A, B, and E, MCM 2–5 and 7(Mini-
chromosome maintenance), CDC20, PLK1, ESP1, and BUBR1
were all overexpressed throughout all cell cycle phases.However, TGFβ2 was downregulated by itself in G1 to S
phase (Fig. 2B). Five other pathways including the p53 signal
pathway, nitrogen metabolism, MAPK signaling pathway,
focal adhesion, and cytokine–cytokine receptor interaction
signaling pathways were clustered as top hit pathways in both
the 6- and the 24-h H groups. In addition, adipocytokine
signaling pathway, PPAR signaling pathway, and fatty acid
metabolism pathway were only classified in the 24-h H genes.
The results indicated that the genes in the 6-h hypoxia group
promote high activities in MSC cell division and proliferation,
while enhancing the cells' ability to enter the multipotency
lineage in order to adapt to the low oxygen environment. The
genes known to be related in these pathways are DDB2,
DUSP6, GADD45B, IBSP, PAGFA, PPP1R3B, and VEGFA.
However, many genes and pathways not yet revealed in the
context of hypoxia were also identified.








Gene Name % ⁎ Fold Change ⁎⁎
6 hr 24 hr
Ssc.4984 Hs.483444 CXCL14 chemokine (C-X-C motif) ligand 14 98 9.53 4.32
Ssc.30876 Hs.660435 PRDM5 PR domain containing 5 97 6.55 5.12
Ssc.21920 Hs.631760 DHRS13 dehydrogenase/reductase (SDR family) member 13 92 4.70 2.90
Ssc.56741 Hs.250666 HES1 hairy and enhancer of split 1, (Drosophila) 100 4.11 2.44
Ssc.9075 Hs.525704 C-JUN C-JUN protein (jun oncogene) 95 3.92 3.64
Ssc.6391 Hs.473721 SLC2A1 solute carrier family 2 (facilitated glucose transporter)
member 1
99 3.73 2.07
Ssc.9399 Hs.592304 ERO1L ERO1-like 98 3.37 2.58
Ssc.20177 Hs.502511 SPI1 spleen focus forming virus (SFFV) proviral integration
oncogene spi1
98 3.01 4.01
Ssc.1674 Hs.655169 SLC2A3 solute carrier family 2 (facilitated glucose transporter),
member 3
90 3.00 3.33
Ssc.26417 Hs.502876 RHOB Ras homolog gene family member B 100 2.76 2.05
Ssc.16443 Hs.144873 BNIP3 BCL2/adenovirus E1B 19 kDa interacting protein 3 90 2.74 2.28
Ssc.19163 Hs.501023 MAXI1 MAX interactor 1 98 2.73 2.85
Ssc.9781 Hs.414795 SERPINE1 serpin peptidase inhibitor, clade E (nexin, plasminogen
activator inhibitor type 1), member 1
91 2.70 2.03
Ssc.55343 Hs.149098 SMTN smoothelin 97 2.63 2.16
Ssc.4538 Hs.25338 PRSS23 protease serine 23 97 2.56 3.46
Ssc.54191 Hs.277035 MGLL monoglyceride lipase 91 2.56 3.28
Ssc.6382 Hs.458513 PPP1R3B protein phosphatase 1, regulatory (inhibitor) subunit 3B 91 2.43 2.27
Ssc.55173 Hs.535898 PDGFA platelet-derived growth factor alpha polypeptide 90 2.42 2.16
Ssc.56186 Hs.593339 HMGB1 high-mobility group box 1 100 2.40 2.41
Ssc.20115 Hs.655280 DDB2 damage-specific DNA binding protein 2 48 kDa 91 2.23 2.11
Ssc.5157 Hs.635508 FXYD6 FXYD domain containing ion transport regulator 6 95 2.22 4.25
Ssc.50004 Hs.50382 TJP2 tight junction protein 2 (zona occludens 2) 92 2.21 2.28
Ssc.16373 Hs.707993 SOX9 SRY (sex determining region Y)-box 9 98 2.20 2.32
Ssc.9380 Hs.110571 GADD45B growth arrest and DNA-damage-inducible beta 99 2.20 2.21
Ssc.24770 Hs.444975 PLAGL1 pleiomorphic adenoma gene-like 1 95 2.16 2.04
Ssc.57541 Hs.73793 VEGFA vascular endothelial growth factor 95 2.09 2.30
Ssc.57662 Hs.466937 PPP1R13L protein phosphatase 1 regulatory (inhibitor)
subunit 13 like
93 2.07 2.07
Ssc.36928 Hs.464071 PGD phosphogluconate dehydrogenase 94 0.50 0.33
Ssc.53998 Hs.590876 TBC1D10 TBC1 domain family, member 20 100 0.49 0.50
Ssc.3921 Hs.468410 EPAS1 endothelial PAS domain protein 1 94 0.48 0.42
Ssc.13553 Hs.657795 GNA14 guanine nucleotide binding protein (G protein), alpha 14 99 0.48 0.49
Ssc.32207 Hs.19904 CTH cystathionase (cystathionine gamma-lyase) 90 0.44 0.42
Ssc.24968 Hs.271695 NOB1 NIN1/RPN12 binding protein 1 homolog (S. cerevisiae) 95 0.43 0.47
Ssc.25164 Hs.298654 DUSP6 dual specificity phosphatase 6 100 0.41 0.43
Ssc.19398 Hs.603111 RND2 Rho family GTPase 2 99 0.40 0.38
Ssc.3476 Hs.495728 PIR pirin (iron-binding nuclear protein) 94 0.39 0.31
Ssc.26696 Hs.128055 OSGIN1 oxidative stress induced growth inhibitor 1 91 0.39 0.36
Ssc.23488 Hs.271510 GSR glutathione reductase 98 0.38 0.34
Ssc.40123 Hs.659346 CPXM1 carboxypeptidase X (M14 family), member 1 90 0.36 0.30
Ssc.16231 Hs.160562 IGF1 insulin-like growth factor 98 0.32 0.20
Ssc.5776 Hs.524741 ARPC3 actin related protein 2/3 complex subunit 3 21 kDa 100 0.32 0.42
Ssc.15970 Hs.248122 MCHR17 melanin-concentrating hormone receptor 1 98 0.31 0.28
Ssc.6928 Hs.76392 ALDH1A1 aldehyde dehydrogenase 1 family member A1 95 0.27 0.27
Ssc.54099 Hs.522891 CXCL12 chemokine (C-X-C motif) ligand 12
(stromal cell-derived factor 1)
95 0.26 0.22
Ssc.57526 Hs.708065 TXNRD1 thioredoxin reductase 1 94 0.24 0.23
Ssc.8789 Hs.355284 SRXN1 sulfiredoxin 1 homolog (S. cerevisiae) 99 0.24 0.19
⁎ % of protein squence similarty in porcine and human.
⁎⁎ fold chang rate in hypoxia to normoxia.
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Table 2 Functional classification of hypoxic genes at the 6- and 24-h time points
Biological process (GO term level 4) 6 hour (n=167) ⁎⁎ 24 hour (n=82) ⁎⁎
count % p value count % p value
cell cycle phase 38 22.8 1.6E-24 n/a n/a n/a
mitosis 35 21.0 7.1E-28 n/a n/a n/a
negative regulation of cellular process 28 16.8 4.5E-04 13 15.9 5.8E-02
cell development 28 16.8 1.9E-03 13 15.9 1.0E-01
regulation of cell cycle 28 16.8 1.8E-10 6 7.3 2.5E-01
positive regulation of cellular process 24 14.4 1.9E-03 14 17.1 1.1E-02
programmed cell death 23 13.8 2.0E-04 11 13.4 3.0E-02
transcription from RNA polymerase II promoter 17 10.2 6.9E-03 9 11.0 6.5E-02
positive regulation of cellular metabolic process 12 7.2 1.2E-02 7 8.5 5.1E-02
organ morphogenesis 11 6.6 2.9E-02 8 9.8 1.7E-02
positive regulation of transcription 11 6.6 6.1E-03 6 7.3 5.9E-02
negative regulation of cellular metabolic process 10 6.0 4.5E-02 5 6.1 2.4E-01
blood vessel morphogenesis (angiogenesis) 7 4.2 1.5E-02 5 6.1 2.2E-02
nitrogen compound biosynthetic process 6 3.6 1.0E-02 4 4.9 8.6E-01
cytoskeleton-dependent intracellular transport 6 3.6 2.1E-02 n/a n/a n/a
organ development (lung, respiratory, ect.) n/a n/a n/a 17 20.7 7.1E-03
cellular homeostasis n/a n/a n/a 7 8.5 1.5E-02
regulation of protein metabolic process n/a n/a n/a 6 7.3 4.8E-02
⁎⁎ The number of genes in DAVID database.
121The transcriptional changes of pig MSC in hypoxiaThe top hits of the biological processes at GO level 4 (Gene
Ontology term) in both the 6- and the 24-h Hs are summarized
in Table 2. As shown, 24 and 13 genes in the 6-h and 24-h H
groups, respectively, were enhanced for the function of
programmed cell death. Seven genes in the 6-h H and five in
24-h H were associated with blood vessel morphogenesis.
Thirty-eight genes in the 6-h H were associated with cell
cycle phases, with 35 of the 38 connected to the mitosis
phase. Seventeen genes in the 24-h H group were involved in
organ development (respiratory development) (EASY score P
valueb0.001). Adding the results of the pathway analysis and
GO together the 6-h H genes were, however, more specific to
the mitosis phase of cell division, whereas the 24-h H group
genes were more related to cell adhesion regulation of cell
morphogenesis, catabolism, and lipid metabolism.
Prediction and validation of novel hypoxic targets
A typical approach for a microarray study is to identify
unique differential regulated targets. In order to find the
hypoxia-induced targets, PAM was performed on each pair of
the sample groups with the purpose of cross-validating the
identification of differentially expressed genes. Hypoxia and
normoxia were segregated into separate groups and then
distinguished between the 24-h hypoxia and normoxia at an
error rate less than 0.001. Based on these results, 87
transcripts were identified to be differentially expressed in
all H vs N in the prediction analysis but also existed in the
significant modulated gene list of SAM and ANOVAs (Table 1;
Fig. 3). Of these 87 swine transcripts, 47 are homologous
genes that are accessible to the human and/or pig genome
database. The hypoxia-enriched genes SOX9, HES1, CXCL14,
DDB2, BNIP3, PDGFA, SERPINE, and IGF1 are not only known
to be involved in hypoxia-induced biological activities but
also reportedly play a role in multi-influenced differentiation
in MSC (Martin-Rendon et al., 2007; Bellot et al., 2009;Kanichai et al., 2008; Saed et al., 2002; Le et al., 2004; Suga
et al., 2009). Nevertheless, other upregulated genes in this
dataset, FXYD6, PRDM5 and PRSS23, were not reported to be
modulated by hypoxia.
Among all the differentially expressed genes identified,
we selected several genes that were related to cell
proliferation, differentiation, and growth factors for micro-
array data validation by qRT-PCR. Fig. 3 shows mRNA
significantly differential expression levels in microarray
and qRT-PCR. Six genes, ARNT (HIF1β), VEGFA, CXCL14,
FXYD6, BNIP3, and HES1, were relatively overexpressed in
hypoxic groups. IGF1 and OSG1N1 were all downregulated in
the hypoxic MSC groups compared with their corresponding
normoxic controls. Similarly, VEGFA, CXCL14, and FAXYD6
transcripts were all upregulated in the hypoxic swine aortic
fibroblast samples whereas IGF1 and OSGIN1 were down-
regulated in this group as well. ARNT, the HIF1β (aryl
hydrocarbon receptor nuclear translocator), were neither
significantly up- nor downexpressed in hypoxic-treated aFBC
vs normoxic cells. However, the ARNT expression pattern
tended to downregulate along with the time of cell exposure
to hypoxia (Fig. 3C).
Discussion
The purpose of this study was to catch dynamic activities in
large-scaled transcripts that were induced by hypoxia (swine
BM-MSC during exposure to 1% oxygen and 8% CO2 condi-
tions). As a large animal model, swine have been used for
many preclinical trials. As a result, swine models have been
invaluable in elucidating general strategies, biological path-
ways, and processes, and for guiding the development of
hypotheses to test. Unfortunately, functional genomic
information about swine is incomplete, which limits the
ability to characterize regulated gene expression profiles. To
solve this problem, we manually searched the latest
122 S. Wang et al.transcript information in a pig genomic resource, using each
pig transcript Unigene ID and/or GenBank Accession Number
in accordance with the corresponding human transcript with
over 80% protein sequence similarity. As a result, over 50% of
the hypoxic genes in our porcine gene dataset matched with
the corresponding human genes. These conclusions allowed
us to obtain additional information from human genomic
resources. In this study, we characterized swine BM-MSC
response when exposed to hypoxia at three different time
points. We showed that (1) a large number of genes involved
in cell development, program cell death, and organ
morphogenesis were differentially regulated in the three
hypoxia groups; (2) the dominant upregulated genes in 6-h H
MSC were involved in cell cycle phase, primarily in the
mitosis phase, whereas genes in 24-h H MSC were more
involved in organ development; and (3) the MSC response to
hypoxia was somewhat similar for all time points, but
different between 6- and 24-h H time points. Our data
revealed that overall the changes of gene regulation in the
12-h H group are less than those of 6- and 24-h Hs (Fig. 1D).
This finding is similar to previous reports (Ohnishi et al.,
2007; Wu et al., 2007).
Twenty-one genes in the 6-h H group were selected;
they were involved in the cell cycle pathway (KEGG) via
pathway analysis. Surprisingly, 20 genes including MCMs,
CDCs, Cyclins, GADD45, PCNA, BUB1B, PLK1, ORCIL, ESPL1
and E2F were upregulated and distributed into all four
phases of cell cycle. The growth arrest DNA-damage-
inducible gene β (GADD45β) is a member of the group of
genes that respond to environmental stress by mediating
activation of the p38/JNK pathway (Engelmann et al.,
2008; Papa et al., 2004). The proliferating cell nuclear
antigen (PCNA) that responds to DNA damage is involved in
the RAD6-dependent DNA repair pathway, and is likely to
be a cancer risk biomarker (Kimos et al., 2004; Lee et al.,
2006). The one downregulated gene, TGFβ2 has been
reported to be upregulated under hypoxic conditions and
plays a role in cellular proliferation, differentiation and
other functions in various cell types. It has been reportedFigure 2 Pathway analysis. (A) Pie graphs illustrate the proportion
Illustration of the hypoxia-induced genes employed in the cell cycle p
genes up- or downregulated in 6-h H group, respectively.that TGFβ2 is induced by HIFs and is thus overexpressed in
human peritoneal fibroblasts and human peritoneal meso-
thelial cells when exposed to hypoxia (Saed et al., 2002;
Zhang et al., 2003). Contrarily, the TGFβ2 was found
downregulated in the 6-h H vs N group in our data set.
TGFβ2 also showed a 1.8-fold downregulation in both the 12-
and 24-h H groups. This disagreement may be due to cDNA
sequence variation of swine and human genes. As a result of
expression level variation, the cell responds to a low oxygen
environment, resulting in TGFβ2 to regulate differently in
BM-MSC and other cell types. Combining the 21 gene
functional specialties together, the cell cycling regulation
should be triggered by the stress of cells under hypoxic
conditions. The numbers of signaling pathways such as MAPK,
p53, TGFβ, and VEGFA signaling and metabolic pathways
were also activated and played a role in hypoxic cell
starvation in order to adapt to the changing environment.
MSC have shown proangiogenic properties in several in
vivo models (Barry, 2003; Al-Khaldi et al., 2003; Arnhold
et al., 2007). The biologic process of angiogenesis is
activated in the cells that survive in hypoxic or ischemic
conditions (Brat et al., 2003; Kenneth and Rocha, 2008;
Dioum et al., 2008). VEGFA is a well-known factor that
plays an important role in angiogenesis in the face of
hypoxia or ischemia. To better understand our data sets
and look for new hypoxic targets or angiogenic cofactors, a
set of hypoxic regulated genes was mapped on the HIF and
VEGFA network (Supplemental Fig. 2). The proteins of
many genes like JUN, FGF1, BCL2, FLT1, PDGFA, and
SERPINE1 appear in the HIF and VEGFA molecular network.
These genes were all upregulated in this study. However,
some genes, IGF and IGF1R, PLAU, and ORIGN1 (oxidative
stress-induced growth inhibitor 1), were all downregulated.
These genes are well known for their involvement with cell
survival regulation after the stress of ultraviolet radiation,
inflammation, or starvation.
In our study, several genes that have not been reported
previously for their involvement in the regulation of cells
surviving under hypoxic conditions but consistentlys of the regulated genes enriched in cell signaling pathways. (B)
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124 S. Wang et al.appeared in our statistical dataset were discovered.
Therefore, we carefully validated and confirmed these
genes' expression levels in normoxia and hypoxia using
conventional PCR and qRT-PCR. The genes' FXYD domains
containing ion transport regulator 6 (FXYD6) (Sweadner and
Rael, 2000) and protease serine 23 (PRSS23) were over-
expressed under the hypoxic conditions of this study, and
were located on cellular membranes via gene ontology.
These genes may be the novel hypoxic targets of BM-MSC
for further study.Figure 3 Hypoxic targets prediction and data validation. (A) C
biomarker prediction by PAM. Upregulated genes are designated by r
to left. (B) Dynamic gene expression in sample by GeneSpring9.0. The
time of cell treated with hypoxia. (C) qRT-PCR validation. Six individ
y-axis stands for the relative expression level between hypoxia andOxygen is crucial to cell survival and function. Different
cell types behave differently under hypoxic stress. The stress
in cells always interacts with a complex of various
environmental factors, which contribute in various degrees
to the overall stress. However, oxygen shortage-induced
factors also have some common signals and response path-
ways in diverse cells, and therefore, these factors have the
potential to modulate the effects of each other through cross
talking. Furthermore, the cells that survive under hypoxic
conditions may partially achieve their functional stagesentroids from comparison between hypoxia and normoxia for
ightward-extending bars; those that are downregulated protrude
y-axis represents gene expression level and x-axis stands for the
ual genes were tested for the validation of microarray data. The
normoxia (fold change, hypoxia/normoxia).
Figure 3 (continued).
125The transcriptional changes of pig MSC in hypoxia(Ohnishi et al., 2007; Detmar et al., 1997; Das et al., 2000;
Early et al., 2007). Our limited hypoxic aFBC transcriptional
data showed that these transcripts, VEGFA, CXCL14, FXYD6,
IGF1, and OSIGN1 alteration, are comparable in both aFBC
and MSC under hypoxic conditions. These results indicate
that these genes interact similarly with the hypoxic
environment in both swine aFBC and MSC. Previous studies
have shown that hypoxia can trigger cell cycle pathways and
activate serial biological responses, such as stress response,
cell injury, and damage responses in many cell types,
including fibroblasts and stem cells (Ohnishi et al., 2007;
Detmar et al., 1997; Das et al., 2000; Early et al., 2007).
Fibroblasts play a major role in extracellular matrix turnover
and involve in vasculogenesis and tissue remodeling under
hypoxic conditions (Karakiulakis et al., 2007); (Kietzmann
et al., 2001). MSC are multilineage cells that are able to
differentiate into diverse cell types when exposure to a low
oxygen setting. Therefore, the MSC have a wide range of
roles in response to hypoxia in cells, such as cell prolifera-
tion, angiogenesis, repair, and remodeling of the wounded
tissues and blood vessels (Zhou et al., 2009).
In summary, our data confirmed and expanded previous
observations regarding genes associated with hypoxia in
adult swine bone marrow-derived mesenchymal stem cells.
We obtained hypoxic transcriptional expression patterns at
6- and 24-h time points, which demonstrated molecular
events of swine MSC survival under low oxygen conditions.Finally, several new hypoxic targets have been identified for
further study that may have clinical ramifications.
Materials and methods
Swine bone marrow-derived mesenchymal stem
cell isolation
Animal application and procedures were approved by the
Animal Care and Use Committee of the National Heart, Lung,
and Blood Institute, and the investigation conformed to the
Guide for the Care and Use of Laboratory Animals (National
Academy Press, 1996, Washington, DC). Bone marrow
aspirates were collected from 15 Yorkshire domestic pigs
(age, 81±10 days; female, 13, male, 2). The bone marrow
mononuclear cells were separated from red blood cells and
granulocytes by a modified protocol using lymphocyte
separation medium (Mediatech Inc., Manassas, VA). The
mononuclear cells were divided into two populations and
resuspended either in endothelial growth media-2 (EGM-2)
(Lonza, Allendale, NJ) with 5% FBS (fetal bovine serum) or
Dubellco's modified Eagle medium (DMEM) (Invitrogen) with
10% FBS, transferred into two noncoated T-75 cell culture
flasks, and then placed in a 37 °C and 5% CO2 humidified
cell culture incubator for MSC adhesion and expansion.
Three days later, the nonadherent cells were collected
126 S. Wang et al.and transferred into a fresh cell culture flask and the
adherent cells were left in the cell culture flasks for
expansion and passage. The cultured BM-MSC were charac-
terized by FACS for cell surface markers, and adipogenesis
and osteogenesis assays for multipotent differentiation
lineages (Zhou et al., 2009).
Primary swine aorta-derived fibroblasts isolation
Under sterile conditions, the healthy adult swine thoracic
aorta was dissected and rinsed in serum-free DMEM supple-
mented with 1X PenStrep. After trim off of the adventitial
tissues, the aorta was then incubated with 0.25% trypsin for
20 min at 37 °C. The aortic endothelium was then flushed
with serum-free DMEM. The yielding cells were collected,
washed two times with serum-free medium, centrifuged,
and cultured in EGM2 (containing FGF and three other growth
factors) with 5% FBS in a 37 °C and 5% CO2 humidified cell
culture for 3 days. After 3 passages, when the cells were
uniform with typical spindle-shaped fibroblast morphologies,
they were replaced with DMEM/10% FBS for two more
passages. Then the cells were characterized through
immunocytochemistry and FACS after the two passages
with DMEM (Supplemental Fig. 1).
Exposure to hypoxia
The BM-MSC were seeded at a density of 2×105 cells/well in
a 6-well plate and cultured under normal conditions
overnight. The cells were then placed with 1 ml of fresh
cell culture medium (DMEM or EGM2) and either incubated
in a monitored hypoxic chamber at 37 °C, 1% O2, and 8 %
CO2 (BioSpherix, Redfield, NY) for 6, 12, 24, and 48 h for
the hypoxia groups (6-h H, 12-h H, 24-h, and 48-h H) or
cultured under normal conditions as the normoxia control
group (N). The aFBC were seeded into 6-well plates with
fresh medium under normoxic conditions for overnight.
Then, the cells with 1 ml fresh medium were placed into
either the hypoxic chamber (hypoxia) or the normal cell
culture incubator (normoxia as the control group) for 6, 24,
and 48 h.
RNA preparation and porcine genome array
A total of 72 RNA samples from 15 swine BN-MSC and 3 swine
aFBC were isolated using the RNeasy kit (Qiagen, Valencia,
CA). Twenty MSC RNA samples of 5Ns and 15Hs (5 samples in
each time point: 6-h H, 12-h H, and 24-h H) were hybridized
to a porcine cDNA microarray (GeneChip Porcine Genome
Affymetix, Santa Clara, CA), which contains 23 937 probe
sets representing 20 201 genes in a pig. An additional 40 MSC
RNAs and 12 aFBC RNAs from 13 pigs were prepared for data
confirmation using qRT-PCR.
Data normalization and pattern recognition
RAM normalization of signal intensities from each hybridized
array was conducted using the GenespringGX9.0 software
package (Agilent Technologies, Foster City, CA). Within
normalized log ratios of gene expression levels, we first
identified genes with significant differential expression withnormoxia (baseline control) and three hypoxic groups using
Significance Analysis of Microarray (Stanford University, CA)
and Prediction Analysis of Microarray (Tibshirani et al., 2002)
in R package and analysis of variance in GenespringGX9.0
package. Differentially expressed genes were determined
based on a minimum of 2-fold change, the false discovery
rate (FDRb0.1) via permutations of repeated measure-
ments in SAM (Tusher et al., 2001), and false negative rate
(P valueb0.05) according to ANOVA.
Homologous search and functional classification of the
significant modulated genes were analyzed via NCBI Pig
Genomic Resources (http://www.ncbi.nlm.nih.gov/projects/
genome/guide/pig/), GenBank, Affymetix database, and
DAVID Bioinformatics Resources 2008 (http://david.abcc.
ncifcrf.gov/home.jsp ).
qRT-PCR
Template cDNAs were synthesized from 500 ng of total RNA
using the SuperScript III kit (Invitrogen Life Technologies,
Carlsbad, CA) and random hexamers. The cDNA template was
mixed with PCR, containing 100 nM of both forward and
reverse primers, Universal PCRmaster mix with SYBR Green 1
(QuantiTect SYBR Green RT-PCR Kit, QIAGEN Inc., Valencia,
CA). PCR amplification was performed on a multicolor real-
time PCR detection system (IQ 5, Bio-Rad Lab. Inc., Hercules,
CA) as follows: 10 min of initial denaturation at 95 °C
followed by 45 cycles of 15 s of denaturation at 95 °C, and
1 min of annealing/extension at 60 °C.
Each sample was analyzed in duplicate. Three RT-PCR
were performed for the examination of each signal gene. For
normalization, the average of the expression level of two
housekeeper genes, swine Beta-actin (β-actin) and beta 2
microglobulin (β2M), was used. Analysis of relative quanti-
fication was performed as previously described (Wang et al.,
2006). The sequences of primers are listed in Supplemental
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